117 related articles for article (PubMed ID: 12198225)
1. Efficacy of haemodiafiltration treatment with PEPA dialysis membranes in plasma free light chain removal in a patient with primary amyloidosis.
Machiguchi T; Tamura T; Yoshida H
Nephrol Dial Transplant; 2002 Sep; 17(9):1689-91. PubMed ID: 12198225
[No Abstract] [Full Text] [Related]
2. Effect of dialysis on serum/plasma levels of free immunoglobulin light chains in end-stage renal disease patients.
Cohen G; Rudnicki M; Schmaldienst S; Hörl WH
Nephrol Dial Transplant; 2002 May; 17(5):879-83. PubMed ID: 11981077
[TBL] [Abstract][Full Text] [Related]
3. Extended high cutoff on-line hemodiafiltration is superior to extended high cutoff hemodialysis in removal of free light chain immunoglobulin of myeloma cast nephropathy.
Susantitaphong P; Tiranathanagul K; Eiam-Ong S
Artif Organs; 2012 Sep; 36(9):845-6. PubMed ID: 22497276
[No Abstract] [Full Text] [Related]
4. Serum Free Light Chains Removal by HFR Hemodiafiltration in Patients with Multiple Myeloma and Acute Kidney Injury: a Case Series.
Menè P; Giammarioli E; Fofi C; Antolino G; Verde G; Tafuri A; Punzo G; Festuccia F
Kidney Blood Press Res; 2018; 43(4):1263-1272. PubMed ID: 30078004
[TBL] [Abstract][Full Text] [Related]
5. The double polymethylmethacrylate filter (DELETE system) in the removal of light chains in chronic dialysis patients with multiple myeloma.
Santoro A; Grazia M; Mancini E
Blood Purif; 2013; 35 Suppl 2():5-13. PubMed ID: 23676829
[TBL] [Abstract][Full Text] [Related]
6. [On-line HDF].
Muraoka Y
Nihon Rinsho; 2004 May; 62 Suppl 5():257-60. PubMed ID: 15197926
[No Abstract] [Full Text] [Related]
7. [Amyloidosis].
Homma N
Nihon Rinsho; 2004 May; 62 Suppl 5():607-11. PubMed ID: 15197994
[No Abstract] [Full Text] [Related]
8. Reduction of free immunoglobulin light chains using adsorption properties of hemodiafiltration with endogenous reinfusion.
Testa A; Dejoie T; Lecarrer D; Wratten M; Sereni L; Renaux JL
Blood Purif; 2010; 30(1):34-6. PubMed ID: 20588010
[TBL] [Abstract][Full Text] [Related]
9. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.
Lornoy W; Becaus I; Billiouw JM; Sierens L; Van Malderen P; D'Haenens P
Nephrol Dial Transplant; 2000; 15 Suppl 1():49-54. PubMed ID: 10737167
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy.
Rousseau-Gagnon M; Agharazii M; De Serres SA; Desmeules S
PLoS One; 2015; 10(10):e0140463. PubMed ID: 26466100
[TBL] [Abstract][Full Text] [Related]
11. Hemodiafiltration improves free light chain removal and normalizes κ/λ ratio in hemodialysis patients.
Bourguignon C; Chenine L; Bargnoux AS; Leray-Moragues H; Canaud B; Cristol JP; Morena M
J Nephrol; 2016 Apr; 29(2):251-257. PubMed ID: 26022721
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
Hasegawa M; Kondo F; Yamamoto K; Murakami K; Tomita M; Nabeshima K; Nakai S; Kato M; Ohashi A; Arai J; Hiki Y; Ishii J; Emi N; Sugiyama S; Yuzawa Y
Ther Apher Dial; 2010 Oct; 14(5):451-6. PubMed ID: 21175542
[TBL] [Abstract][Full Text] [Related]
13. [The clinical significance of serum free light chain in primary systemic amyloidosis].
Zhai YP; Song P; Li F; Liu HN; Yu YP; Zhou XG; Shi P; An ZM; Zhou X; Zhang CN
Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):404-7. PubMed ID: 21624224
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
Kopeć J
Przegl Lek; 2006; 63(7):567-72. PubMed ID: 17203811
[TBL] [Abstract][Full Text] [Related]
15. Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeloma: a pilot study of intact and truncated forms of light chains and their charge properties.
Kaplan B; Ramirez-Alvarado M; Dispenzieri A; Zeldenrust SR; Leung N; Livneh A; Gallo G
Clin Chem Lab Med; 2008; 46(3):335-41. PubMed ID: 18254719
[TBL] [Abstract][Full Text] [Related]
16. Internal hemodiafiltration versus low-flux bicarbonate dialysis: Results from a long-term prospective study.
Righetti M; Filiberti O; Ranghino A; Ferrario G; Milani S; Serbelloni P; Guida GE; Tommasi A
Int J Artif Organs; 2010 Nov; 33(11):796-802. PubMed ID: 21140355
[TBL] [Abstract][Full Text] [Related]
17. New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation.
Girnius S; Seldin DC; Cibeira MT; Sanchorawala V
J Clin Oncol; 2013 Jul; 31(21):2749-50. PubMed ID: 23775968
[No Abstract] [Full Text] [Related]
18. Online high-efficiency haemodiafiltration achieves higher serum free light chain removal than high-flux haemodialysis in multiple myeloma patients: preliminary quantitative study.
Granger Vallée A; Chenine L; Leray-Moragues H; Patrier L; Cognot C; Cartron G; Cristol JP; Canaud B
Nephrol Dial Transplant; 2011 Nov; 26(11):3627-33. PubMed ID: 21508098
[TBL] [Abstract][Full Text] [Related]
19. Citrate Extended High Cut-Off Hemodiafiltration for Renal Recovery in Patients With Multiple Myeloma.
Marn Pernat A; Medved B; Gubenšek J; Premru V; Knap B; Buturovic-Ponikvar J; Ponikvar R
Ther Apher Dial; 2016 Jun; 20(3):251-5. PubMed ID: 27312910
[TBL] [Abstract][Full Text] [Related]
20. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes.
Palladini G; Dispenzieri A; Gertz MA; Kumar S; Wechalekar A; Hawkins PN; Schönland S; Hegenbart U; Comenzo R; Kastritis E; Dimopoulos MA; Jaccard A; Klersy C; Merlini G
J Clin Oncol; 2012 Dec; 30(36):4541-9. PubMed ID: 23091105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
